IBDEI0Q2 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12484,1,4,0)
 ;;=4^Renal Dis NOS w/o HTN-Postpartum
 ;;^UTILITY(U,$J,358.3,12484,2)
 ;;=^270917
 ;;^UTILITY(U,$J,358.3,12485,0)
 ;;=646.33^^62^747^33
 ;;^UTILITY(U,$J,358.3,12485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12485,1,3,0)
 ;;=3^646.33
 ;;^UTILITY(U,$J,358.3,12485,1,4,0)
 ;;=4^Recurnt pregnan loss-Antepartum
 ;;^UTILITY(U,$J,358.3,12485,2)
 ;;=^339731
 ;;^UTILITY(U,$J,358.3,12486,0)
 ;;=646.43^^62^747^26
 ;;^UTILITY(U,$J,358.3,12486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12486,1,3,0)
 ;;=3^646.43
 ;;^UTILITY(U,$J,358.3,12486,1,4,0)
 ;;=4^Neuritis in pregnan-Antepartum
 ;;^UTILITY(U,$J,358.3,12486,2)
 ;;=^270926
 ;;^UTILITY(U,$J,358.3,12487,0)
 ;;=646.44^^62^747^27
 ;;^UTILITY(U,$J,358.3,12487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12487,1,3,0)
 ;;=3^646.44
 ;;^UTILITY(U,$J,358.3,12487,1,4,0)
 ;;=4^Neuritis in pregnan-Postpartum
 ;;^UTILITY(U,$J,358.3,12487,2)
 ;;=^270927
 ;;^UTILITY(U,$J,358.3,12488,0)
 ;;=646.53^^62^747^5
 ;;^UTILITY(U,$J,358.3,12488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12488,1,3,0)
 ;;=3^646.53
 ;;^UTILITY(U,$J,358.3,12488,1,4,0)
 ;;=4^Asympt bacteriuria-Antepartum
 ;;^UTILITY(U,$J,358.3,12488,2)
 ;;=^270932
 ;;^UTILITY(U,$J,358.3,12489,0)
 ;;=646.54^^62^747^6
 ;;^UTILITY(U,$J,358.3,12489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12489,1,3,0)
 ;;=3^646.54
 ;;^UTILITY(U,$J,358.3,12489,1,4,0)
 ;;=4^Asympt bacteriuria-Postpartum
 ;;^UTILITY(U,$J,358.3,12489,2)
 ;;=^270933
 ;;^UTILITY(U,$J,358.3,12490,0)
 ;;=646.63^^62^747^17
 ;;^UTILITY(U,$J,358.3,12490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12490,1,3,0)
 ;;=3^646.63
 ;;^UTILITY(U,$J,358.3,12490,1,4,0)
 ;;=4^GU tract Infection-Antepartum
 ;;^UTILITY(U,$J,358.3,12490,2)
 ;;=^270938
 ;;^UTILITY(U,$J,358.3,12491,0)
 ;;=646.64^^62^747^18
 ;;^UTILITY(U,$J,358.3,12491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12491,1,3,0)
 ;;=3^646.64
 ;;^UTILITY(U,$J,358.3,12491,1,4,0)
 ;;=4^GU tract Infection-Postpartum
 ;;^UTILITY(U,$J,358.3,12491,2)
 ;;=^270939
 ;;^UTILITY(U,$J,358.3,12492,0)
 ;;=646.73^^62^747^21
 ;;^UTILITY(U,$J,358.3,12492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12492,1,3,0)
 ;;=3^646.73
 ;;^UTILITY(U,$J,358.3,12492,1,4,0)
 ;;=4^Liver/Bil tract d/o-Antepartum
 ;;^UTILITY(U,$J,358.3,12492,2)
 ;;=^340638
 ;;^UTILITY(U,$J,358.3,12493,0)
 ;;=647.03^^62^747^38
 ;;^UTILITY(U,$J,358.3,12493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12493,1,3,0)
 ;;=3^647.03
 ;;^UTILITY(U,$J,358.3,12493,1,4,0)
 ;;=4^Syphillis-Antepartum
 ;;^UTILITY(U,$J,358.3,12493,2)
 ;;=^270957
 ;;^UTILITY(U,$J,358.3,12494,0)
 ;;=647.04^^62^747^39
 ;;^UTILITY(U,$J,358.3,12494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12494,1,3,0)
 ;;=3^647.04
 ;;^UTILITY(U,$J,358.3,12494,1,4,0)
 ;;=4^Syphillis-Postpartum
 ;;^UTILITY(U,$J,358.3,12494,2)
 ;;=^270958
 ;;^UTILITY(U,$J,358.3,12495,0)
 ;;=647.13^^62^747^19
 ;;^UTILITY(U,$J,358.3,12495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12495,1,3,0)
 ;;=3^647.13
 ;;^UTILITY(U,$J,358.3,12495,1,4,0)
 ;;=4^Gonorrhea-Antepartum
 ;;^UTILITY(U,$J,358.3,12495,2)
 ;;=^270963
 ;;^UTILITY(U,$J,358.3,12496,0)
 ;;=647.14^^62^747^20
 ;;^UTILITY(U,$J,358.3,12496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12496,1,3,0)
 ;;=3^647.14
 ;;^UTILITY(U,$J,358.3,12496,1,4,0)
 ;;=4^Gonorrhea-Postpartum
 ;;^UTILITY(U,$J,358.3,12496,2)
 ;;=^270964
 ;;^UTILITY(U,$J,358.3,12497,0)
 ;;=647.23^^62^747^28
 ;;^UTILITY(U,$J,358.3,12497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12497,1,3,0)
 ;;=3^647.23
 ;;^UTILITY(U,$J,358.3,12497,1,4,0)
 ;;=4^Oth Veneral Disease-Antepartum
 ;;^UTILITY(U,$J,358.3,12497,2)
 ;;=^270969
 ;;
 ;;$END ROU IBDEI0Q2
